Suppr超能文献

十年风险方程预测已确诊动脉粥样硬化性心血管疾病患者的心力衰竭发生率。

Ten-Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations.

机构信息

Department of Cardiology The Alfred Hospital Melbourne Victoria Australia.

Faculty of Medicine Monash University Melbourne Victoria Australia.

出版信息

J Am Heart Assoc. 2024 Jun 4;13(11):e034254. doi: 10.1161/JAHA.124.034254. Epub 2024 May 23.

Abstract

BACKGROUND

Ten-year risk equations for incident heart failure (HF) are available for the general population, but not for patients with established atherosclerotic cardiovascular disease (ASCVD), which is highly prevalent in HF cohorts. This study aimed to develop and validate 10-year risk equations for incident HF in patients with known ASCVD.

METHODS AND RESULTS

Ten-year risk equations for incident HF were developed using the United Kingdom Biobank cohort (recruitment 2006-2010) including participants with established ASCVD but free from HF at baseline. Model performance was validated using the Australian Baker Heart and Diabetes Institute Biobank cohort (recruitment 2000-2011) and compared with the performance of general population risk models. Incident HF occurred in 13.7% of the development cohort (n=31 446, median 63 years, 35% women, follow-up 10.7±2.7 years) and in 21.3% of the validation cohort (n=1659, median age 65 years, 25% women, follow-up 9.4±3.7 years). Predictors of HF included in the sex-specific models were age, body mass index, systolic blood pressure (treated or untreated), glucose (treated or untreated), cholesterol, smoking status, QRS duration, kidney disease, myocardial infarction, and atrial fibrillation. ASCVD-HF equations had good discrimination and calibration in development and validation cohorts, with superior performance to general population risk equations.

CONCLUSIONS

ASCVD-specific 10-year risk equations for HF outperform general population risk models in individuals with established ASCVD. The ASCVD-HF equations can be calculated from readily available clinical data and could facilitate screening and preventative treatment decisions in this high-risk group.

摘要

背景

针对一般人群,已经有用于预测心力衰竭(HF)的 10 年风险方程,但对于 HF 患者中常见的已确诊动脉粥样硬化性心血管疾病(ASCVD)患者,则尚无此类方程。本研究旨在为已知 ASCVD 的 HF 患者开发和验证 10 年 HF 风险方程。

方法和结果

本研究使用英国生物库队列(招募 2006-2010 年)来开发用于 HF 新发病例的 10 年风险方程,该队列包括基线时已确诊 ASCVD 但 HF 病史的患者。使用澳大利亚贝克心脏与糖尿病研究所生物库队列(招募 2000-2011 年)验证模型性能,并与一般人群风险模型的性能进行比较。队列中有 13.7%的患者发生 HF(n=31446,中位年龄 63 岁,35%为女性,随访时间 10.7±2.7 年),10.7±2.7 年)。纳入性别特异性模型的 HF 预测因子包括年龄、体重指数、收缩压(治疗或未治疗)、血糖(治疗或未治疗)、胆固醇、吸烟状况、QRS 持续时间、肾脏疾病、心肌梗死和心房颤动。ASCVD-HF 方程在开发和验证队列中具有良好的区分度和校准度,性能优于一般人群风险方程。

结论

针对 ASCVD 患者的 HF 10 年风险方程优于一般人群风险模型,可用于 ASCVD 患者的 HF 预测。ASCVD-HF 方程可通过现有临床数据计算,有助于对高危人群进行筛查和预防治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed7/11255645/26d87461c1de/JAH3-13-e034254-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验